Literature DB >> 6268661

Monocyte chemotactic peptide receptor. Functional characteristics and ligand-induced regulation.

J B Weinberg, J J Muscato, J E Niedel.   

Abstract

Monocytes, macrophages, and neutrophils will demonstrate several important cellular functions in response to synthetic formylated oligopeptides. N-formyl-norleucyl-leucyl-phenylalanyl-norleucyl-tyrosyl-lysine (fNLPNTL) was a potent chemoattractant for human blood monocytes; a 1.0-nM concentration induced a maximal chemotactic response. Binding of 125I-labeled fNLPNTL to the monocyte formyl peptide receptor was rapid, specific, and saturable at 4, 24, or 37 degrees C. At 4 degrees C, monocytes from several different donors demonstrated between 10,000 and 18,000 receptors/cell with a dissociation constant (Kd) of 1.7-2.7 nM. The association of the 125I peptide with the cells was irreversible at the elevated temperatures and exceeded the amount of surface receptor by approximately four-fold, suggesting receptor-mediated peptide endocytosis. Processing of rhodamine-labeled fNLPNTL by monocytes was observed directly by video intensification microscopy. At 37 degrees C, diffuse membrane fluorescence was seen initially, followed by rapid aggregation and internalization of the peptide. Monocytes incubated with fNLPNTL displayed a temperature dependent loss of surface binding capacity (receptor down-regulation). This decrease was due to a decrease in surface receptor number rather than to a decrease in receptor affinity. A dose-response curve for peptide-induced receptor down-regulation correlated with a dose-response curve for 125I-labeled fNLPNTL uptake, suggesting that each uptake event led to the loss of one surface receptor. Surface receptor replenishment following down-regulation was rapid and not dependent on new protein synthesis, but was inversely related to both the time and peptide concentration used to induce down-regulation. An exact correlation between receptor down-regulation and functional deactivation of the chemotactic response could not be demonstrated.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6268661      PMCID: PMC370842          DOI: 10.1172/jci110296

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

1.  Isolation of lymphocytes, granulocytes and macrophages.

Authors:  A Bøyum
Journal:  Scand J Immunol       Date:  1976-06       Impact factor: 3.487

2.  Characterization of the effects of endotoxin on macrophage tumor cell killing.

Authors:  J B Weinberg; H A Chapman; J B Hibbs
Journal:  J Immunol       Date:  1978-07       Impact factor: 5.422

Review 3.  The regulatory role of macrophages in antigenic stimulation.

Authors:  E R Unanue
Journal:  Adv Immunol       Date:  1972       Impact factor: 3.543

4.  Human mononuclear leukocyte chemotaxis: a quantitative assay for humoral and cellular chemotactic factors.

Authors:  R Snyderman; L C Altman; M S Hausman; S E Mergenhagen
Journal:  J Immunol       Date:  1972-03       Impact factor: 5.422

5.  Detection of endotoxin in human blood and demonstration of an inhibitor.

Authors:  J Levin; P A Tomasulo; R S Oser
Journal:  J Lab Clin Med       Date:  1970-06

6.  Cytochemical identification of monocytes and granulocytes.

Authors:  L T Yam; C Y Li; W H Crosby
Journal:  Am J Clin Pathol       Date:  1971-03       Impact factor: 2.493

7.  N-formylmethionyl peptides as chemoattractants for leucocytes.

Authors:  E Schiffmann; B A Corcoran; S M Wahl
Journal:  Proc Natl Acad Sci U S A       Date:  1975-03       Impact factor: 11.205

8.  Demonstration of a receptor on rabbit neutrophils for chemotactic peptides.

Authors:  S Aswanikumar; B Corcoran; E Schiffmann; A R Day; R J Freer; H J Showell; E L Becker
Journal:  Biochem Biophys Res Commun       Date:  1977-01-24       Impact factor: 3.575

9.  Specific receptor sites for chemotactic peptides on human polymorphonuclear leukocytes.

Authors:  L T Williams; R Snyderman; M C Pike; R J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

10.  Studies of the macrophage complement receptor. Alteration of receptor function upon macrophage activation.

Authors:  C Bianco; F M Griffin; S C Silverstein
Journal:  J Exp Med       Date:  1975-06-01       Impact factor: 14.307

View more
  14 in total

1.  Blood mononuclear cell nitric oxide production and plasma cytokine levels in healthy gabonese children with prior mild or severe malaria.

Authors:  D J Perkins; P G Kremsner; D Schmid; M A Misukonis; M A Kelly; J B Weinberg
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  Role of monocyte-acquired hemozoin in suppression of macrophage migration inhibitory factor in children with severe malarial anemia.

Authors:  Gordon A Awandare; Yamo Ouma; Collins Ouma; Tom Were; Richard Otieno; Christopher C Keller; Gregory C Davenport; James B Hittner; John Vulule; Robert Ferrell; John M Ong'echa; Douglas J Perkins
Journal:  Infect Immun       Date:  2006-10-23       Impact factor: 3.441

3.  Loss and recovery of sensitivity of guinea-pig isolated ileum to the spasmogenic action of the complement peptide C5adesArg.

Authors:  B Damerau; J Roesler; W Vogt
Journal:  Br J Pharmacol       Date:  1985-01       Impact factor: 8.739

4.  Receptor-mediated modulation of human monocyte, neutrophil, lymphocyte, and platelet function by phorbol diesters.

Authors:  B J Goodwin; J B Weinberg
Journal:  J Clin Invest       Date:  1982-10       Impact factor: 14.808

5.  Reduced peripheral PGE2 biosynthesis in Plasmodium falciparum malaria occurs through hemozoin-induced suppression of blood mononuclear cell cyclooxygenase-2 gene expression via an interleukin-10-independent mechanism.

Authors:  Christopher C Keller; James B Hittner; Benjamin K Nti; J Brice Weinberg; Peter G Kremsner; Douglas J Perkins
Journal:  Mol Med       Date:  2004 Jan-Jun       Impact factor: 6.354

6.  Acquisition of hemozoin by monocytes down-regulates interleukin-12 p40 (IL-12p40) transcripts and circulating IL-12p70 through an IL-10-dependent mechanism: in vivo and in vitro findings in severe malarial anemia.

Authors:  Christopher C Keller; Ouma Yamo; Collins Ouma; John Michael Ong'echa; David Ounah; James B Hittner; John M Vulule; Douglas J Perkins
Journal:  Infect Immun       Date:  2006-09       Impact factor: 3.441

7.  Differential regulation of beta-chemokines in children with Plasmodium falciparum malaria.

Authors:  Daniel O Ochiel; Gordon A Awandare; Christopher C Keller; James B Hittner; Peter G Kremsner; J Brice Weinberg; Douglas J Perkins
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

8.  Abnormal monocyte chemotaxis in patients with chronic purulent rhinosinusitis: an effect of retroviral p15E-related factors in serum.

Authors:  E M van de Plassche-Boers; M Tas; M de Haan-Meulman; M Kleingeld; H A Drexhage
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

9.  Elevated nitric oxide production in children with malarial anemia: hemozoin-induced nitric oxide synthase type 2 transcripts and nitric oxide in blood mononuclear cells.

Authors:  Christopher C Keller; Peter G Kremsner; James B Hittner; Mary A Misukonis; J Brice Weinberg; Douglas J Perkins
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

10.  Rat and human neutrophil N-formyl-peptide chemotactic receptors. Species difference in the glycosylation of similar 35-38 kDa polypeptide cores.

Authors:  J J Remes; U E Petäjä-Repo; H J Rajaniemi
Journal:  Biochem J       Date:  1991-07-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.